New stitching trick may improve colon cancer surgery
NCT ID NCT04223141
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested a new way to reconnect the colon after removing a cancerous section using a robot. The technique uses a special double purse-string stitch and a single stapler. Thirty-nine patients with sigmoid colon cancer were included, and the study looked at how well the technique worked and how many complications occurred.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Single-stapled double purse-string anastomotic (SIA) technique
- What this could lead to
- If successful, this technique could reduce surgical complications and improve recovery for patients undergoing robotic sigmoid cancer surgery.
- What could go wrong
- This is a small, single-center study with no control group, so results may not apply broadly. The technique may not be safer or faster than standard methods.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLO-RECTAL CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Vejle Hospital, Department of Surgery
Vejle, DK7100, Denmark
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new drug combo revive Immunotherapy's power against resistant tumors?
- Can a registry make endoscopic procedures safer and more effective?
- A new clue in the fight against colorectal cancer recurrence?
- Does practice make perfect? a study probes how a Surgeon's learning curve impacts cancer surgery success
- One simple score to rate colorectal cancer surgery quality?
- Engineered virus joins forces with immunotherapy to fight resistant cancers